Nox Reveals Next-Gen PSG System adminJuly 28, 2023 Ingvar Hjalmarsson, chief product officer of Nox Medical, says in a release, “The system provides an untethered setup and features bedside control through the Noxturnal App to perform bio-calibration, review signal quality, conduct impedance checks, and view live traces—ultimately two huge differentiating factors among other PSG devices on the market.” Nox A1s can be configured through cloud connectivity with Nox Self-Applied Somnography (Nox SAS), allowing patients the ability to self-apply the device in the comfort of their own home. The Nox SAS has been used in more than 6,000 sleep studies worldwide, but is currently only available for research purposes. The Nox A1 first launched in Europe in 2014. In June 2021, Nox Medical introduced the Nox A1s to its sales network and distributors and as of October 8, 2021, it officially launches to the market, though availability may vary.
